AMY BROIDRICK

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Qualigen Therapeutics, Inc.

Filing Date Source Excerpt
2022-07-13 “From 2016 to July 2020, Ms. Broidrick served as Senior Vice President, Global Head of Corporate Development of Viking Therapeutics, Inc.... Before that, she was Vice President, Head of Global Marketing Excellence and Business Innovation...”

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-29